Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66.4M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
30.9M
-
Shares change
-
-802K
-
Total reported value, excl. options
-
$846M
-
Value change
-
-$21.9M
-
Number of buys
-
42
-
Number of sells
-
-28
-
Price
-
$27.41
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q1 2019
88 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q1 2019.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.9M shares
of 66.4M outstanding shares and own 46.47% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (3.28M shares), MPM ASSET MANAGEMENT LLC (3.07M shares), BAKER BROS. ADVISORS LP (2.71M shares), TRV GP, LLC (1.98M shares), RA CAPITAL MANAGEMENT, LLC (1.88M shares), FMR LLC (1.59M shares), BlackRock Inc. (1.53M shares), VANGUARD GROUP INC (1.15M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.01M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.